25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

LAB (Standard Biotools Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Standard Biotools Inc together

I guess you are interested in Standard Biotools Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Standard Biotools Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Standard Biotools Inc’s Price Targets

I'm going to help you getting a better view of Standard Biotools Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Standard Biotools Inc

I send you an email if I find something interesting about Standard Biotools Inc.

1. Quick Overview

1.1. Quick analysis of Standard Biotools Inc (30 sec.)










1.2. What can you expect buying and holding a share of Standard Biotools Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$1.20
Expected worth in 1 year
$0.81
How sure are you?
17.5%

+ What do you gain per year?

Total Gains per Share
$-0.40
Return On Investment
-30.7%

For what price can you sell your share?

Current Price per Share
$1.29
Expected price per share
$1.02 - $1.51
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Standard Biotools Inc (5 min.)




Live pricePrice per Share (EOD)
$1.29
Intrinsic Value Per Share
$-4.35 - $-2.44
Total Value Per Share
$-3.15 - $-1.24

2.2. Growth of Standard Biotools Inc (5 min.)




Is Standard Biotools Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$454.5m$123.8m$357.6m74.3%

How much money is Standard Biotools Inc making?

Current yearPrevious yearGrowGrow %
Making money-$33.1m-$22.4m-$10.6m-32.2%
Net Profit Margin-79.9%-71.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Standard Biotools Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Standard Biotools Inc?

Welcome investor! Standard Biotools Inc's management wants to use your money to grow the business. In return you get a share of Standard Biotools Inc.

First you should know what it really means to hold a share of Standard Biotools Inc. And how you can make/lose money.

Speculation

The Price per Share of Standard Biotools Inc is $1.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Standard Biotools Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Standard Biotools Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.20. Based on the TTM, the Book Value Change Per Share is $-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $0.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Standard Biotools Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-5.3%-0.09-6.9%-0.06-4.8%-0.08-6.2%-0.07-5.6%-0.06-4.5%
Usd Book Value Change Per Share-0.06-4.5%-0.10-7.7%0.4736.2%0.107.4%0.043.1%0.021.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.2%0.000.1%0.000.1%
Usd Total Gains Per Share-0.06-4.5%-0.10-7.7%0.4736.2%0.107.6%0.043.3%0.021.6%
Usd Price Per Share1.08-1.63-2.44-1.84-3.22-5.62-
Price to Earnings Ratio-3.92--4.75--10.10--6.71--19.46--33.59-
Price-to-Total Gains Ratio-18.77--23.27--23.82--27.58--67.13--129.27-
Price to Book Ratio0.90-1.26--1.88--3.06-6.93-24.95-
Price-to-Total Gains Ratio-18.77--23.27--23.82--27.58--67.13--129.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.29
Number of shares775
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.100.04
Usd Total Gains Per Share-0.100.04
Gains per Quarter (775 shares)-76.7732.79
Gains per Year (775 shares)-307.08131.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-307-3176126121
20-614-62411251252
30-921-93117377383
40-1228-123822502514
50-1535-154528628645
60-1842-185233753776
70-2150-215939879907
80-2457-24664410051038
90-2764-27735011301169
100-3071-30805612561300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.062.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%3.017.00.015.0%7.033.00.017.5%12.048.02.019.4%
Dividend per Share0.00.04.00.0%3.00.09.025.0%3.00.017.015.0%3.00.037.07.5%3.00.059.04.8%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%3.017.00.015.0%7.033.00.017.5%12.048.02.019.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Standard Biotools Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.058-0.099+72%0.467-112%0.095-161%0.041-242%0.020-385%
Book Value Per Share--1.2021.287-7%0.343+251%0.479+151%0.408+194%0.329+266%
Current Ratio--6.1174.865+26%3.289+86%4.392+39%3.381+81%3.328+84%
Debt To Asset Ratio--0.2160.252-14%0.865-75%0.764-72%0.712-70%0.709-70%
Debt To Equity Ratio--0.2750.339-19%0.332-17%0.223+23%1.222-78%2.622-90%
Dividend Per Share----0%0.000-100%0.003-100%0.002-100%0.001-100%
Enterprise Value--541546240.000773927612.500-30%767501336.000-29%590668511.740-8%1060625535.268-49%1904792585.498-72%
Eps---0.069-0.089+29%-0.062-10%-0.080+17%-0.072+5%-0.058-16%
Ev To Ebitda Ratio---6.151-6.906+12%-11.132+81%-7.047+15%-40.549+559%-54.239+782%
Ev To Sales Ratio--3.3194.586-28%5.948-44%4.355-24%7.949-58%16.324-80%
Free Cash Flow Per Share---0.093-0.083-11%-0.069-26%-0.071-25%-0.056-40%-0.040-57%
Free Cash Flow To Equity Per Share---0.094-0.138+48%-0.086-8%-0.046-51%-0.033-64%-0.022-76%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.442----------
Intrinsic Value_10Y_min---4.352----------
Intrinsic Value_1Y_max---0.172----------
Intrinsic Value_1Y_min---0.310----------
Intrinsic Value_3Y_max---0.572----------
Intrinsic Value_3Y_min---1.047----------
Intrinsic Value_5Y_max---1.039----------
Intrinsic Value_5Y_min---1.903----------
Market Cap466002159.360+12%408486240.000610008112.500-33%880527336.000-54%672047511.740-39%1165810335.268-65%2030943660.498-80%
Net Profit Margin---0.638-0.799+25%-0.713+12%-1.002+57%-0.891+40%-0.733+15%
Operating Margin---0.642-0.796+24%-0.697+9%-0.988+54%-0.880+37%-0.717+12%
Operating Ratio--1.8081.836-2%1.655+9%1.883-4%1.740+4%1.635+11%
Pb Ratio1.073+16%0.8991.261-29%-1.879+309%-3.056+440%6.934-87%24.950-96%
Pe Ratio-4.686-19%-3.923-4.748+21%-10.101+158%-6.714+71%-19.462+396%-33.590+756%
Price Per Share1.290+16%1.0801.633-34%2.438-56%1.842-41%3.216-66%5.617-81%
Price To Free Cash Flow Ratio-3.452-19%-2.890-5.564+93%-14.098+388%-9.251+220%-28.018+869%-51.575+1685%
Price To Total Gains Ratio-22.415-19%-18.766-23.267+24%-23.817+27%-27.576+47%-67.128+258%-129.267+589%
Quick Ratio--7.1265.769+24%3.617+97%5.332+34%3.720+92%3.625+97%
Return On Assets---0.045-0.051+14%-0.053+18%-0.061+36%-0.067+49%-0.060+32%
Return On Equity---0.057-0.069+20%-0.044-23%-0.038-34%-0.236+312%-0.251+339%
Total Gains Per Share---0.058-0.099+72%0.467-112%0.098-159%0.042-236%0.021-373%
Usd Book Value--454595000.000481477750.000-6%123852750.000+267%178541750.000+155%150733850.000+202%120358625.000+278%
Usd Book Value Change Per Share---0.058-0.099+72%0.467-112%0.095-161%0.041-242%0.020-385%
Usd Book Value Per Share--1.2021.287-7%0.343+251%0.479+151%0.408+194%0.329+266%
Usd Dividend Per Share----0%0.000-100%0.003-100%0.002-100%0.001-100%
Usd Enterprise Value--541546240.000773927612.500-30%767501336.000-29%590668511.740-8%1060625535.268-49%1904792585.498-72%
Usd Eps---0.069-0.089+29%-0.062-10%-0.080+17%-0.072+5%-0.058-16%
Usd Free Cash Flow---35337000.000-30972250.000-12%-24970000.000-29%-25833416.667-27%-20329650.000-42%-14490700.000-59%
Usd Free Cash Flow Per Share---0.093-0.083-11%-0.069-26%-0.071-25%-0.056-40%-0.040-57%
Usd Free Cash Flow To Equity Per Share---0.094-0.138+48%-0.086-8%-0.046-51%-0.033-64%-0.022-76%
Usd Market Cap466002159.360+12%408486240.000610008112.500-33%880527336.000-54%672047511.740-39%1165810335.268-65%2030943660.498-80%
Usd Price Per Share1.290+16%1.0801.633-34%2.438-56%1.842-41%3.216-66%5.617-81%
Usd Profit---26033000.000-33190250.000+27%-22492500.000-14%-29448666.667+13%-26297400.000+1%-20990925.000-19%
Usd Revenue--40795000.00042421750.000-4%31690250.000+29%32750916.667+25%33031150.000+24%30320325.000+35%
Usd Total Gains Per Share---0.058-0.099+72%0.467-112%0.098-159%0.042-236%0.021-373%
 EOD+5 -3MRQTTM+22 -15YOY+14 -253Y+17 -225Y+19 -2010Y+16 -23

3.3 Fundamental Score

Let's check the fundamental score of Standard Biotools Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.686
Price to Book Ratio (EOD)Between0-11.073
Net Profit Margin (MRQ)Greater than0-0.638
Operating Margin (MRQ)Greater than0-0.642
Quick Ratio (MRQ)Greater than17.126
Current Ratio (MRQ)Greater than16.117
Debt to Asset Ratio (MRQ)Less than10.216
Debt to Equity Ratio (MRQ)Less than10.275
Return on Equity (MRQ)Greater than0.15-0.057
Return on Assets (MRQ)Greater than0.05-0.045
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Standard Biotools Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.304
Ma 20Greater thanMa 501.123
Ma 50Greater thanMa 1001.110
Ma 100Greater thanMa 2001.147
OpenGreater thanClose1.190
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Standard Biotools Inc

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well as genes and their functions. The company provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Standard BioTools Inc. was incorporated in 1999 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2025-06-29 20:48:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Standard Biotools Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -63.8%Β means thatΒ $-0.64 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Standard Biotools Inc:

  • The MRQ is -63.8%. The company is making a huge loss. -2
  • The TTM is -79.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-63.8%TTM-79.9%+16.1%
TTM-79.9%YOY-71.3%-8.6%
TTM-79.9%5Y-89.1%+9.2%
5Y-89.1%10Y-73.3%-15.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-63.8%-7.2%-56.6%
TTM-79.9%-10.2%-69.7%
YOY-71.3%-10.9%-60.4%
3Y-100.2%-12.8%-87.4%
5Y-89.1%-10.3%-78.8%
10Y-73.3%-9.3%-64.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Standard Biotools Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • -4.5% Return on Assets means thatΒ Standard Biotools Inc generatedΒ $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Standard Biotools Inc:

  • The MRQ is -4.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.5%TTM-5.1%+0.6%
TTM-5.1%YOY-5.3%+0.2%
TTM-5.1%5Y-6.7%+1.6%
5Y-6.7%10Y-6.0%-0.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.5%-2.1%-2.4%
TTM-5.1%-2.3%-2.8%
YOY-5.3%-3.3%-2.0%
3Y-6.1%-2.7%-3.4%
5Y-6.7%-2.6%-4.1%
10Y-6.0%-2.4%-3.6%
4.3.1.3. Return on Equity

Shows how efficient Standard Biotools Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • -5.7% Return on Equity means Standard Biotools Inc generated $-0.06Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Standard Biotools Inc:

  • The MRQ is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.7%TTM-6.9%+1.1%
TTM-6.9%YOY-4.4%-2.4%
TTM-6.9%5Y-23.6%+16.7%
5Y-23.6%10Y-25.1%+1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.7%-1.8%-3.9%
TTM-6.9%-2.3%-4.6%
YOY-4.4%-3.1%-1.3%
3Y-3.8%-3.8%+0.0%
5Y-23.6%-4.2%-19.4%
10Y-25.1%-6.1%-19.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Standard Biotools Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Standard Biotools Inc is operatingΒ .

  • Measures how much profit Standard Biotools Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • An Operating Margin of -64.2%Β means the company generated $-0.64 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Standard Biotools Inc:

  • The MRQ is -64.2%. The company is operating very inefficient. -2
  • The TTM is -79.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-64.2%TTM-79.6%+15.5%
TTM-79.6%YOY-69.7%-9.9%
TTM-79.6%5Y-88.0%+8.4%
5Y-88.0%10Y-71.7%-16.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.2%-12.1%-52.1%
TTM-79.6%-13.6%-66.0%
YOY-69.7%-9.9%-59.8%
3Y-98.8%-11.1%-87.7%
5Y-88.0%-9.5%-78.5%
10Y-71.7%-7.3%-64.4%
4.3.2.2. Operating Ratio

Measures how efficient Standard Biotools Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 1.81 means that the operating costs are $1.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Standard Biotools Inc:

  • The MRQ is 1.808. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.836. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.808TTM1.836-0.028
TTM1.836YOY1.655+0.182
TTM1.8365Y1.740+0.096
5Y1.74010Y1.635+0.105
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8081.391+0.417
TTM1.8361.361+0.475
YOY1.6551.272+0.383
3Y1.8831.335+0.548
5Y1.7401.342+0.398
10Y1.6351.321+0.314
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Standard Biotools Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Standard Biotools Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 6.12Β means the company has $6.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Standard Biotools Inc:

  • The MRQ is 6.117. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.865. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.117TTM4.865+1.252
TTM4.865YOY3.289+1.576
TTM4.8655Y3.381+1.484
5Y3.38110Y3.328+0.053
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1172.525+3.592
TTM4.8652.625+2.240
YOY3.2892.651+0.638
3Y4.3922.907+1.485
5Y3.3813.539-0.158
10Y3.3283.320+0.008
4.4.3.2. Quick Ratio

Measures if Standard Biotools Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • A Quick Ratio of 7.13Β means the company can pay off $7.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Standard Biotools Inc:

  • The MRQ is 7.126. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.769. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.126TTM5.769+1.357
TTM5.769YOY3.617+2.152
TTM5.7695Y3.720+2.048
5Y3.72010Y3.625+0.095
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1261.107+6.019
TTM5.7691.412+4.357
YOY3.6171.652+1.965
3Y5.3321.816+3.516
5Y3.7202.145+1.575
10Y3.6252.375+1.250
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Standard Biotools Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Standard Biotools IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Standard Biotools Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.22Β means that Standard Biotools Inc assets areΒ financed with 21.6% credit (debt) and the remaining percentage (100% - 21.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Standard Biotools Inc:

  • The MRQ is 0.216. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.252. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.252-0.036
TTM0.252YOY0.865-0.613
TTM0.2525Y0.712-0.460
5Y0.71210Y0.709+0.004
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2160.400-0.184
TTM0.2520.410-0.158
YOY0.8650.391+0.474
3Y0.7640.388+0.376
5Y0.7120.414+0.298
10Y0.7090.455+0.254
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Standard Biotools Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 27.5% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Standard Biotools Inc:

  • The MRQ is 0.275. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.339. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.339-0.064
TTM0.339YOY0.332+0.007
TTM0.3395Y1.222-0.883
5Y1.22210Y2.622-1.400
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.554-0.279
TTM0.3390.636-0.297
YOY0.3320.589-0.257
3Y0.2230.638-0.415
5Y1.2220.647+0.575
10Y2.6220.754+1.868
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Standard Biotools Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Standard Biotools Inc to theΒ Medical Devices industry mean.
  • A PE ratio of -3.92 means the investor is paying $-3.92Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Standard Biotools Inc:

  • The EOD is -4.686. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.923. Based on the earnings, the company is expensive. -2
  • The TTM is -4.748. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.686MRQ-3.923-0.763
MRQ-3.923TTM-4.748+0.825
TTM-4.748YOY-10.101+5.354
TTM-4.7485Y-19.462+14.714
5Y-19.46210Y-33.590+14.129
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.686-1.165-3.521
MRQ-3.923-1.449-2.474
TTM-4.748-1.183-3.565
YOY-10.101-1.829-8.272
3Y-6.714-1.328-5.386
5Y-19.462-1.482-17.980
10Y-33.590-1.607-31.983
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Standard Biotools Inc:

  • The EOD is -3.452. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.890. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.564. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.452MRQ-2.890-0.562
MRQ-2.890TTM-5.564+2.674
TTM-5.564YOY-14.098+8.534
TTM-5.5645Y-28.018+22.454
5Y-28.01810Y-51.575+23.557
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.452-2.407-1.045
MRQ-2.890-3.182+0.292
TTM-5.564-1.554-4.010
YOY-14.098-3.394-10.704
3Y-9.251-2.971-6.280
5Y-28.018-2.902-25.116
10Y-51.575-3.379-48.196
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Standard Biotools Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 0.90 means the investor is paying $0.90Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Standard Biotools Inc:

  • The EOD is 1.073. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.899. Based on the equity, the company is cheap. +2
  • The TTM is 1.261. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.073MRQ0.899+0.175
MRQ0.899TTM1.261-0.363
TTM1.261YOY-1.879+3.140
TTM1.2615Y6.934-5.673
5Y6.93410Y24.950-18.016
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.0731.916-0.843
MRQ0.8991.993-1.094
TTM1.2612.254-0.993
YOY-1.8792.634-4.513
3Y-3.0562.740-5.796
5Y6.9343.884+3.050
10Y24.9504.281+20.669
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Standard Biotools Inc.

4.8.3. Insider Transactions

Insiders are holding 1.533% of the shares of Standard Biotools Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-05-23Michael EgholmSELL54730.94
2025-05-23Sean MackaySELL132170.94
2025-05-23Hanjoon Alex KimSELL14280.94
2025-05-22Hanjoon Alex KimSELL13551
2025-05-22Michael EgholmSELL51161
2025-05-22Sean MackaySELL125361
2025-05-21Hanjoon Alex KimSELL14071.03
2025-05-21Michael EgholmSELL47191.03
2025-05-21Sean MackaySELL128381.03
2025-02-28Casdin Partners Master Fund, LBUY48209591.06
2024-08-26Casdin Partners Master Fund, LBUY1500002.15
2024-08-23Casdin Partners Master Fund, LBUY2921002.13
2024-08-21Casdin Partners Master Fund, LBUY5000001.9
2024-08-19Casdin Partners Master Fund, LBUY2500001.85
2024-08-14Casdin Partners Master Fund, LBUY12000001.59
2024-08-12Casdin Partners Master Fund, LBUY5000001.64
2024-08-09Casdin Partners Master Fund, LBUY5254081.61
2024-08-07Casdin Partners Master Fund, LBUY5000001.57
2024-08-05Casdin Partners Master Fund, LBUY2000001.58
2024-08-02Casdin Partners Master Fund, LBUY10000001.63
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Tax Provision  128-735563118154272-423-151
Income Tax Expense  128-735563118154272-423-151



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets579,597
Total Liabilities125,002
Total Stockholder Equity454,595
 As reported
Total Liabilities 125,002
Total Stockholder Equity+ 454,595
Total Assets = 579,597

Assets

Total Assets579,597
Total Current Assets344,019
Long-term Assets235,578
Total Current Assets
Cash And Cash Equivalents 150,880
Short-term Investments 107,182
Net Receivables 35,480
Inventory 42,125
Other Current Assets 8,352
Total Current Assets  (as reported)344,019
Total Current Assets  (calculated)344,019
+/-0
Long-term Assets
Property Plant Equipment 71,015
Goodwill 111,719
Intangible Assets 28,057
Long-term Assets Other 24,787
Long-term Assets  (as reported)235,578
Long-term Assets  (calculated)235,578
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities56,236
Long-term Liabilities68,766
Total Stockholder Equity454,595
Total Current Liabilities
Short-term Debt 6,334
Accounts payable 11,778
Other Current Liabilities 20,798
Total Current Liabilities  (as reported)56,236
Total Current Liabilities  (calculated)38,910
+/- 17,326
Long-term Liabilities
Long term Debt 299
Capital Lease Obligations 31,231
Long-term Liabilities Other 3,490
Long-term Liabilities  (as reported)68,766
Long-term Liabilities  (calculated)35,020
+/- 33,746
Total Stockholder Equity
Common Stock397
Retained Earnings -1,211,684
Accumulated Other Comprehensive Income 1,169
Other Stockholders Equity 1,664,713
Total Stockholder Equity (as reported)454,595
Total Stockholder Equity (calculated)454,595
+/-0
Other
Capital Stock397
Cash and Short Term Investments 258,062
Common Stock Shares Outstanding 378,228
Current Deferred Revenue17,326
Liabilities and Stockholders Equity 579,597
Net Debt -119,350
Net Invested Capital 454,894
Net Working Capital 287,783
Property Plant and Equipment Gross 148,078
Short Long Term Debt Total 31,530



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312008-12-312008-06-302007-12-31
> Total Assets 
54,776
49,678
32,354
32,153
0
0
22,090
24,801
94,718
85,655
82,602
79,326
70,666
64,932
117,095
113,732
113,237
111,965
114,241
116,915
424,723
417,746
410,393
407,559
395,031
389,129
378,487
371,061
354,435
342,034
320,421
306,395
292,468
278,709
291,996
287,351
269,702
259,103
252,290
303,647
291,447
283,793
269,394
264,812
290,219
282,348
322,977
324,757
305,198
289,315
282,188
275,214
271,938
441,122
414,915
390,310
371,654
355,827
339,285
323,067
777,667
708,732
681,539
612,344
579,597
579,597612,344681,539708,732777,667323,067339,285355,827371,654390,310414,915441,122271,938275,214282,188289,315305,198324,757322,977282,348290,219264,812269,394283,793291,447303,647252,290259,103269,702287,351291,996278,709292,468306,395320,421342,034354,435371,061378,487389,129395,031407,559410,393417,746424,723116,915114,241111,965113,237113,732117,09564,93270,66679,32682,60285,65594,71824,80122,0900032,15332,35449,67854,776
   > Total Current Assets 
50,329
44,395
29,225
28,483
0
0
18,260
20,881
90,843
80,989
76,032
70,033
56,655
55,697
105,544
101,211
98,557
80,542
86,658
104,584
178,813
127,434
132,820
155,897
155,233
143,380
145,450
144,095
137,804
127,044
108,087
96,671
86,112
79,125
96,166
94,801
81,001
75,247
71,860
127,106
111,478
106,779
96,554
96,096
82,433
78,450
122,663
117,663
96,327
78,206
73,465
72,066
73,197
250,877
229,017
208,815
194,928
183,070
170,741
158,215
547,565
480,029
453,607
375,880
344,019
344,019375,880453,607480,029547,565158,215170,741183,070194,928208,815229,017250,87773,19772,06673,46578,20696,327117,663122,66378,45082,43396,09696,554106,779111,478127,10671,86075,24781,00194,80196,16679,12586,11296,671108,087127,044137,804144,095145,450143,380155,233155,897132,820127,434178,813104,58486,65880,54298,557101,211105,54455,69756,65570,03376,03280,98990,84320,88118,2600028,48329,22544,39550,329
       Cash And Cash Equivalents 
34,077
28,966
17,796
14,602
0
0
5,083
5,723
55,831
10,129
11,881
13,553
8,496
9,854
66,011
58,649
61,815
32,290
20,099
35,261
101,024
43,681
30,939
33,713
36,982
23,745
28,817
29,117
42,854
35,898
32,306
35,045
44,097
39,597
60,944
58,056
41,972
39,424
35,829
95,401
65,634
24,046
25,886
21,661
34,992
42,965
72,345
68,520
49,744
30,863
29,309
28,451
29,983
74,361
60,200
81,309
113,663
142,304
79,655
51,704
287,057
269,811
210,647
166,728
150,880
150,880166,728210,647269,811287,05751,70479,655142,304113,66381,30960,20074,36129,98328,45129,30930,86349,74468,52072,34542,96534,99221,66125,88624,04665,63495,40135,82939,42441,97258,05660,94439,59744,09735,04532,30635,89842,85429,11728,81723,74536,98233,71330,93943,681101,02435,26120,09932,29061,81558,64966,0119,8548,49613,55311,88110,12955,8315,7235,0830014,60217,79628,96634,077
       Short-term Investments 
6,286
3,503
0
0
0
0
0
0
21,869
54,222
47,049
39,914
30,382
28,018
20,147
21,362
17,755
28,136
43,580
49,083
42,123
51,063
64,324
81,588
79,424
76,181
68,253
65,855
52,365
50,512
38,941
24,385
6,183
2,434
1,430
5,080
5,282
996
0
0
9,499
44,815
36,875
36,978
13,493
2,431
0
0
0
0
0
0
0
136,850
124,968
84,475
40,874
0
49,195
63,191
175,225
124,902
155,683
126,146
107,182
107,182126,146155,683124,902175,22563,19149,195040,87484,475124,968136,85000000002,43113,49336,97836,87544,8159,499009965,2825,0801,4302,4346,18324,38538,94150,51252,36565,85568,25376,18179,42481,58864,32451,06342,12349,08343,58028,13617,75521,36220,14728,01830,38239,91447,04954,22221,8690000003,5036,286
       Net Receivables 
1,900
2,495
4,706
8,690
0
0
6,886
8,100
7,457
10,316
8,966
9,253
9,764
9,612
10,654
12,900
10,056
10,839
12,413
10,552
18,790
13,329
16,919
22,384
19,577
21,786
26,248
25,457
19,643
18,885
12,835
14,610
14,391
13,659
13,732
15,049
16,267
16,874
18,379
16,651
19,309
19,262
14,014
18,981
14,410
9,983
25,069
25,423
15,412
15,666
13,732
18,320
15,422
10,937
17,294
17,280
14,504
15,119
16,560
19,660
36,012
32,441
35,317
33,608
35,480
35,48033,60835,31732,44136,01219,66016,56015,11914,50417,28017,29410,93715,42218,32013,73215,66615,41225,42325,0699,98314,41018,98114,01419,26219,30916,65118,37916,87416,26715,04913,73213,65914,39114,61012,83518,88519,64325,45726,24821,78619,57722,38416,91913,32918,79010,55212,41310,83910,05612,90010,6549,6129,7649,2538,96610,3167,4578,1006,886008,6904,7062,4951,900
       Inventory 
5,498
6,980
5,456
3,945
0
0
5,568
4,893
4,653
4,850
5,836
5,970
6,444
6,610
7,219
7,169
7,371
7,233
8,021
8,148
13,426
16,357
16,960
15,991
17,394
18,817
19,141
17,924
19,570
18,180
20,838
20,114
19,715
18,765
17,746
15,088
15,253
15,251
15,424
13,003
13,754
14,269
14,998
13,884
16,294
18,900
19,560
19,689
21,892
25,074
24,498
20,825
23,245
22,791
21,946
21,473
22,513
22,080
21,927
20,533
40,359
42,618
42,644
40,737
42,125
42,12540,73742,64442,61840,35920,53321,92722,08022,51321,47321,94622,79123,24520,82524,49825,07421,89219,68919,56018,90016,29413,88414,99814,26913,75413,00315,42415,25115,25315,08817,74618,76519,71520,11420,83818,18019,57017,92419,14118,81717,39415,99116,96016,35713,4268,1488,0217,2337,3717,1697,2196,6106,4445,9705,8364,8504,6534,8935,568003,9455,4566,9805,498
       Other Current Assets 
2,568
2,451
1,267
1,246
0
0
723
2,165
1,033
1,472
2,300
1,343
1,569
1,603
1,513
1,131
3,120
4,088
2,545
1,540
3,450
3,004
3,678
2,221
1,856
2,851
2,991
5,742
3,372
3,569
6,334
2,517
3,452
9,340
4,628
3,056
4,454
5,404
4,456
4,102
6,564
4,387
4,781
4,592
3,244
4,171
5,689
4,031
9,279
6,603
5,926
4,470
4,547
5,938
4,609
4,278
3,374
3,567
3,404
3,127
8,912
10,257
9,316
8,661
8,352
8,3528,6619,31610,2578,9123,1273,4043,5673,3744,2784,6095,9384,5474,4705,9266,6039,2794,0315,6894,1713,2444,5924,7814,3876,5644,1024,4565,4044,4543,0564,6289,3403,4522,5176,3343,5693,3725,7422,9912,8511,8562,2213,6783,0043,4501,5402,5454,0883,1201,1311,5131,6031,5691,3432,3001,4721,0332,165723001,2461,2672,4512,568
   > Long-term Assets 
4,447
5,283
3,129
3,670
0
0
3,830
3,920
3,875
4,666
6,570
9,293
14,011
9,235
11,551
12,521
14,680
31,423
27,583
12,331
245,910
290,312
277,573
251,662
239,798
245,749
233,037
226,966
216,631
214,990
212,334
209,724
206,356
199,584
195,830
192,550
188,701
183,856
180,430
176,541
179,969
177,014
172,840
168,716
207,786
203,898
200,314
207,094
208,871
211,109
208,723
203,148
198,741
190,245
185,898
181,495
176,726
172,757
168,544
164,852
230,102
228,703
227,932
236,464
235,578
235,578236,464227,932228,703230,102164,852168,544172,757176,726181,495185,898190,245198,741203,148208,723211,109208,871207,094200,314203,898207,786168,716172,840177,014179,969176,541180,430183,856188,701192,550195,830199,584206,356209,724212,334214,990216,631226,966233,037245,749239,798251,662277,573290,312245,91012,33127,58331,42314,68012,52111,5519,23514,0119,2936,5704,6663,8753,9203,830003,6703,1295,2834,447
       Property Plant Equipment 
3,378
2,757
2,777
1,930
0
0
2,169
2,328
2,285
2,539
2,569
3,256
3,577
4,024
4,308
4,974
5,019
4,919
5,155
6,818
9,377
11,568
12,668
13,889
14,053
14,102
14,358
15,258
15,370
16,816
17,305
16,525
15,258
13,966
13,335
12,301
11,433
10,424
9,760
8,825
15,411
14,804
13,748
12,916
47,642
46,892
46,000
55,645
61,029
66,435
66,611
65,153
64,088
62,687
61,310
59,535
57,976
56,716
55,729
54,850
77,752
74,100
72,246
71,384
71,015
71,01571,38472,24674,10077,75254,85055,72956,71657,97659,53561,31062,68764,08865,15366,61166,43561,02955,64546,00046,89247,64212,91613,74814,80415,4118,8259,76010,42411,43312,30113,33513,96615,25816,52517,30516,81615,37015,25814,35814,10214,05313,88912,66811,5689,3776,8185,1554,9195,0194,9744,3084,0243,5773,2562,5692,5392,2852,3282,169001,9302,7772,7573,378
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,245
104,245
104,245
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
104,108
106,328
106,328
106,455
106,563
106,456
106,486
106,428
106,379
106,333
106,200
106,069
106,251
106,285
106,287
106,225
106,317
106,269
106,253
106,342
111,297
111,719
111,719111,297106,342106,253106,269106,317106,225106,287106,285106,251106,069106,200106,333106,379106,428106,486106,456106,563106,455106,328106,328104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,108104,245104,245104,24500000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,300
1,237
110,600
107,800
105,000
102,200
99,400
96,600
93,850
91,048
88,246
85,445
82,643
79,800
77,000
74,200
71,400
68,600
65,800
63,000
60,200
57,400
54,600
51,800
49,000
46,200
48,612
45,644
42,955
40,206
38,789
34,082
32,419
27,927
24,875
18,200
15,400
12,600
10,210
7,242
4,200
1,407
24,794
24,078
23,367
28,954
28,057
28,05728,95423,36724,07824,7941,4074,2007,24210,21012,60015,40018,20024,87527,92732,41934,08238,78940,20642,95545,64448,61246,20049,00051,80054,60057,40060,20063,00065,80068,60071,40074,20077,00079,80082,64385,44588,24691,04893,85096,60099,400102,200105,000107,800110,6001,2371,300000000000000000000
       Long-term Assets Other 
1,069
2,526
352
1,740
0
0
321
252
250
787
2,661
3,197
4,369
4,210
4,041
3,881
2,363
3,431
3,288
3,571
6,558
4,405
3,698
3,966
3,729
3,820
3,688
10,059
8,907
8,621
8,278
9,291
9,990
7,310
6,987
7,541
7,360
6,324
6,362
6,208
5,850
6,302
5,984
5,492
5,204
5,034
4,904
4,680
2,597
4,106
3,265
3,689
3,445
3,158
3,119
3,109
2,255
2,512
2,390
1,478
15,635
19,234
25,977
24,829
24,787
24,78724,82925,97719,23415,6351,4782,3902,5122,2553,1093,1193,1583,4453,6893,2654,1062,5974,6804,9045,0345,2045,4925,9846,3025,8506,2086,3626,3247,3607,5416,9877,3109,9909,2918,2788,6218,90710,0593,6883,8203,7293,9663,6984,4056,5583,5713,2883,4312,3633,8814,0414,2104,3693,1972,661787250252321001,7403522,5261,069
> Total Liabilities 
185,107
194,586
190,693
205,772
0
0
23,539
213,968
25,955
23,350
23,451
22,429
18,768
16,012
14,436
13,075
13,113
13,580
17,229
19,797
257,292
255,920
255,838
257,140
252,578
255,912
254,361
256,160
255,458
257,770
252,449
253,162
253,965
254,772
252,926
256,416
221,128
224,270
229,878
231,531
109,202
111,153
106,789
111,200
148,723
149,629
171,004
185,707
182,260
179,865
182,851
180,618
249,825
478,576
477,662
471,777
468,807
469,214
471,005
159,865
200,351
198,471
192,206
140,622
125,002
125,002140,622192,206198,471200,351159,865471,005469,214468,807471,777477,662478,576249,825180,618182,851179,865182,260185,707171,004149,629148,723111,200106,789111,153109,202231,531229,878224,270221,128256,416252,926254,772253,965253,162252,449257,770255,458256,160254,361255,912252,578257,140255,838255,920257,29219,79717,22913,58013,11313,07514,43616,01218,76822,42923,45123,35025,955213,96823,53900205,772190,693194,586185,107
   > Total Current Liabilities 
11,575
15,751
8,521
7,129
0
0
11,443
18,512
18,545
17,759
19,662
20,171
17,743
14,766
13,125
11,597
11,537
11,626
15,043
17,248
25,736
27,306
27,306
29,385
24,904
28,930
27,481
30,081
30,520
32,315
27,915
29,500
31,289
34,324
31,884
33,474
33,704
36,650
38,865
37,582
34,182
37,320
33,366
32,821
35,364
38,348
42,791
54,249
53,529
52,848
47,290
49,568
47,173
42,770
46,169
43,443
43,787
46,840
51,800
109,327
121,554
123,808
120,615
65,894
56,236
56,23665,894120,615123,808121,554109,32751,80046,84043,78743,44346,16942,77047,17349,56847,29052,84853,52954,24942,79138,34835,36432,82133,36637,32034,18237,58238,86536,65033,70433,47431,88434,32431,28929,50027,91532,31530,52030,08127,48128,93024,90429,38527,30627,30625,73617,24815,04311,62611,53711,59713,12514,76617,74320,17119,66217,75918,54518,51211,443007,1298,52115,75111,575
       Short-term Debt 
3,834
6,081
1,034
3,531
0
0
3,020
7,686
7,995
8,310
8,601
8,921
6,343
4,703
1,875
0
0
0
0
703
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,402
6,700
4,726
1,833
2,370
4,340
5,394
2,973
6,050
5,942
5,746
9,891
6,418
6,586
7,863
5,765
10,861
12,407
12,960
63,853
66,324
66,485
61,035
12,456
6,334
6,33412,45661,03566,48566,32463,85312,96012,40710,8615,7657,8636,5866,4189,8915,7465,9426,0502,9735,3944,3402,3701,8334,7266,7007,4020000000000000000000070300001,8754,7036,3438,9218,6018,3107,9957,6863,020003,5311,0346,0813,834
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,838
0
0
833
2,083
3,333
4,583
5,000
59,530
54,656
54,783
54,913
0
0
0054,91354,78354,65659,5305,0004,5833,3332,083833006,838000000000000000000000000000000000000000000000000000
       Accounts payable 
2,725
3,231
2,860
2,224
0
0
1,805
3,155
4,673
2,983
4,679
4,010
4,101
3,295
3,345
2,555
3,214
1,997
3,406
4,353
8,001
7,637
7,276
5,919
5,502
5,964
6,303
6,094
4,439
5,830
4,871
3,967
3,731
3,858
4,721
4,211
5,206
6,642
6,246
4,027
6,936
8,075
5,339
5,152
9,440
9,384
10,971
9,220
12,552
11,224
10,786
10,602
12,517
9,016
9,305
7,914
6,109
6,089
7,327
9,236
13,141
12,570
10,926
12,282
11,778
11,77812,28210,92612,57013,1419,2367,3276,0896,1097,9149,3059,01612,51710,60210,78611,22412,5529,22010,9719,3849,4405,1525,3398,0756,9364,0276,2466,6425,2064,2114,7213,8583,7313,9674,8715,8304,4396,0946,3035,9645,5025,9197,2767,6378,0014,3533,4061,9973,2142,5553,3453,2954,1014,0104,6792,9834,6733,1551,805002,2242,8603,2312,725
       Other Current Liabilities 
2,364
3,935
3,215
4,147
0
0
5,128
6,335
4,315
4,680
4,564
5,229
5,772
5,035
5,771
7,156
6,395
7,412
8,830
10,877
12,404
13,802
13,400
16,538
12,056
15,419
12,999
14,568
16,980
17,457
13,320
16,370
17,658
21,369
17,286
19,025
17,853
19,252
21,108
22,091
7,519
10,573
11,363
14,033
10,887
10,345
12,990
28,581
17,996
11,790
11,410
13,593
10,797
10,764
12,227
14,135
10,106
11,753
18,345
20,572
28,183
29,640
35,218
20,990
20,798
20,79820,99035,21829,64028,18320,57218,34511,75310,10614,13512,22710,76410,79713,59311,41011,79017,99628,58112,99010,34510,88714,03311,36310,5737,51922,09121,10819,25217,85319,02517,28621,36917,65816,37013,32017,45716,98014,56812,99915,41912,05616,53813,40013,80212,40410,8778,8307,4126,3957,1565,7715,0355,7725,2294,5644,6804,3156,3355,128004,1473,2153,9352,364
   > Long-term Liabilities 
173,532
178,835
182,172
198,643
0
0
12,096
195,456
7,410
5,591
3,789
2,258
1,025
1,246
1,311
1,478
1,576
1,954
2,186
2,549
231,556
228,614
228,532
227,755
227,674
226,982
226,880
226,079
224,938
225,455
224,534
223,662
222,676
220,448
221,042
222,942
187,424
187,620
191,013
193,949
75,020
73,833
73,423
78,379
113,359
111,281
128,213
131,458
128,731
127,017
135,561
131,050
202,652
435,806
431,493
428,334
425,020
422,374
419,205
50,538
78,797
74,663
71,591
74,728
68,766
68,76674,72871,59174,66378,79750,538419,205422,374425,020428,334431,493435,806202,652131,050135,561127,017128,731131,458128,213111,281113,35978,37973,42373,83375,020193,949191,013187,620187,424222,942221,042220,448222,676223,662224,534225,455224,938226,079226,880226,982227,674227,755228,532228,614231,5562,5492,1861,9541,5761,4781,3111,2461,0252,2583,7895,5917,410195,45612,09600198,643182,172178,835173,532
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,943
64,044
64,209
100,032
54,384
63,885
62,809
61,734
60,662
59,590
0
0
0
0
0
0
00000059,59060,66261,73462,80963,88554,384100,03264,20964,04453,9430000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311,253
311,253
311,253
311,253
311,253
0
0
0
0
0
0
0
0000000311,253311,253311,253311,253311,25300000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,013
33,347
29,293
65,860
24,275
21,486
20,191
0
18,228
0
0
0
0
0
0
0
000000018,228020,19121,48624,27565,86029,29333,34734,0130000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
620
0
1,052
1,049
0
0
0
0
0
0
0
00000001,0491,0520620000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-130,331
-144,908
-158,339
-173,619
0
0
-1,449
-189,167
68,763
62,305
59,151
56,897
51,898
48,920
102,659
100,657
100,124
98,385
97,012
97,118
167,431
161,826
154,555
150,419
142,453
133,217
124,126
114,901
98,977
84,264
67,972
53,233
38,503
23,937
39,070
30,935
48,574
34,833
22,412
72,116
182,245
172,640
162,605
153,612
141,496
132,719
151,973
139,050
122,938
109,450
99,337
94,596
22,113
-37,454
-62,747
-81,467
-97,153
-113,387
-131,720
163,202
577,316
510,261
489,333
471,722
454,595
454,595471,722489,333510,261577,316163,202-131,720-113,387-97,153-81,467-62,747-37,45422,11394,59699,337109,450122,938139,050151,973132,719141,496153,612162,605172,640182,24572,11622,41234,83348,57430,93539,07023,93738,50353,23367,97284,26498,977114,901124,126133,217142,453150,419154,555161,826167,43197,11897,01298,385100,124100,657102,65948,92051,89856,89759,15162,30568,763-189,167-1,44900-173,619-158,339-144,908-130,331
   Common Stock
10
10
2
2
0
0
13
2
20
20
20
20
20
21
25
25
25
25
26
26
28
28
28
28
29
29
29
29
29
29
29
29
29
29
39
39
39
39
39
49
69
69
70
70
71
71
74
75
75
76
76
77
77
79
79
80
80
81
82
83
387
389
390
396
397
3973963903893878382818080797977777676757574717170706969493939393939292929292929292929292828282826262525252521202020202021300221010
   Retained Earnings -1,211,684-1,185,651-1,151,579-1,124,641-1,078,923-1,000,752-980,976-959,979-942,939-926,096-905,251-875,825-812,286-735,998-726,568-712,725-695,582-676,761-658,735-652,736-639,721-623,641-610,956-598,069-584,316-558,851-544,075-529,325-513,084-500,196-489,738-473,795-456,862-439,477-421,781-401,993-383,375-363,492-350,613-341,344-326,108-310,177-299,233-285,443-272,761-257,347-252,704-248,418-244,373-240,821-237,219-233,067-228,487-221,797-218,340-213,851-206,665-199,327-196,24900-182,425-163,297-149,060-133,798
   Accumulated Other Comprehensive Income 
-135
-241
-556
-504
0
0
-752
-778
-790
-774
-742
-754
-777
-782
-774
-769
-772
-795
-713
-730
-757
-700
-802
-794
-600
-697
-794
-1,144
-885
-858
-911
-760
-725
-648
-731
-574
-532
-504
-516
-687
-677
-623
-758
-582
-885
-809
-289
112
-331
-284
-730
-907
-1,057
-2,253
-2,609
-1,896
-1,328
-1,551
-1,949
-2,221
-1,792
-1,500
-1,409
1,225
1,169
1,1691,225-1,409-1,500-1,792-2,221-1,949-1,551-1,328-1,896-2,609-2,253-1,057-907-730-284-331112-289-809-885-582-758-623-677-687-516-504-532-574-731-648-725-760-911-858-885-1,144-794-697-600-794-802-700-757-730-713-795-772-769-774-782-777-754-742-774-790-778-75200-504-556-241-135
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
822,383
826,559
831,424
835,379
840,545
845,034
847,008
850,063
853,466
856,926
0
0
0
0
0
0
000000856,926853,466850,063847,008845,034840,545835,379831,424826,559822,3830000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
3,592
4,383
5,512
9,308
0
0
195,539
10,936
276,198
276,910
278,213
279,428
281,142
282,748
340,627
342,222
345,244
347,573
350,403
354,465
440,921
447,941
454,562
461,362
469,132
475,229
475,504
479,508
483,208
487,086
490,635
493,441
496,061
498,351
529,500
531,666
562,151
564,623
566,964
631,605
767,169
771,263
774,249
777,765
782,031
786,193
810,923
815,624
818,776
822,383
826,559
831,424
835,379
218,039
533,781
846,445
224,528
536,809
228,617
854,839
1,657,644
1,636,013
1,641,931
1,702,219
1,664,713
1,664,7131,702,2191,641,9311,636,0131,657,644854,839228,617536,809224,528846,445533,781218,039835,379831,424826,559822,383818,776815,624810,923786,193782,031777,765774,249771,263767,169631,605566,964564,623562,151531,666529,500498,351496,061493,441490,635487,086483,208479,508475,504475,229469,132461,362454,562447,941440,921354,465350,403347,573345,244342,222340,627282,748281,142279,428278,213276,910276,19810,936195,539009,3085,5124,3833,592



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue174,432
Cost of Revenue-90,170
Gross Profit84,26284,262
 
Operating Income (+$)
Gross Profit84,262
Operating Expense-259,498
Operating Income-175,236-175,236
 
Operating Expense (+$)
Research Development62,411
Selling General Administrative156,608
Selling And Marketing Expenses0
Operating Expense259,498219,019
 
Net Interest Income (+$)
Interest Income20,199
Interest Expense-3,316
Other Finance Cost-0
Net Interest Income16,883
 
Pretax Income (+$)
Operating Income-175,236
Net Interest Income16,883
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-138,312-212,160
EBIT - interestExpense = -138,312
-138,312
-135,569
Interest Expense3,316
Earnings Before Interest and Taxes (EBIT)-134,996-134,996
Earnings Before Interest and Taxes (EBITDA)-118,135
 
After tax Income (+$)
Income Before Tax-138,312
Tax Provision-573
Net Income From Continuing Ops-138,885-138,885
Net Income-138,885
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses309,189
Total Other Income/Expenses Net36,924-16,883
 

Technical Analysis of Standard Biotools Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Standard Biotools Inc. The general trend of Standard Biotools Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Standard Biotools Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Standard Biotools Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Standard Biotools Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.33 < 1.46 < 1.51.

The bearish price targets are: 1.13 > 1.1 > 1.02.

Know someone who trades $LAB? Share this with them.πŸ‘‡

Standard Biotools Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Standard Biotools Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Standard Biotools Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Standard Biotools Inc. The current macd is 0.04572789.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Standard Biotools Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Standard Biotools Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Standard Biotools Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Standard Biotools Inc Daily Moving Average Convergence/Divergence (MACD) ChartStandard Biotools Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Standard Biotools Inc. The current adx is 26.90.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Standard Biotools Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Standard Biotools Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Standard Biotools Inc. The current sar is 1.59.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Standard Biotools Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Standard Biotools Inc. The current rsi is 62.30. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Standard Biotools Inc Daily Relative Strength Index (RSI) ChartStandard Biotools Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Standard Biotools Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Standard Biotools Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Standard Biotools Inc Daily Stochastic Oscillator ChartStandard Biotools Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Standard Biotools Inc. The current cci is 95.25.

Standard Biotools Inc Daily Commodity Channel Index (CCI) ChartStandard Biotools Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Standard Biotools Inc. The current cmo is 32.34.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Standard Biotools Inc Daily Chande Momentum Oscillator (CMO) ChartStandard Biotools Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Standard Biotools Inc. The current willr is -52.63157895.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Standard Biotools Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Standard Biotools Inc Daily Williams %R ChartStandard Biotools Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Standard Biotools Inc.

Standard Biotools Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Standard Biotools Inc. The current atr is 0.10812146.

Standard Biotools Inc Daily Average True Range (ATR) ChartStandard Biotools Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Standard Biotools Inc. The current obv is 35,938,592.

Standard Biotools Inc Daily On-Balance Volume (OBV) ChartStandard Biotools Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Standard Biotools Inc. The current mfi is 67.04.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Standard Biotools Inc Daily Money Flow Index (MFI) ChartStandard Biotools Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Standard Biotools Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Standard Biotools Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Standard Biotools Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.304
Ma 20Greater thanMa 501.123
Ma 50Greater thanMa 1001.110
Ma 100Greater thanMa 2001.147
OpenGreater thanClose1.190
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Standard Biotools Inc with someone you think should read this too:
  • Are you bullish or bearish on Standard Biotools Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Standard Biotools Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Standard Biotools Inc

I send you an email if I find something interesting about Standard Biotools Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Standard Biotools Inc.

Receive notifications about Standard Biotools Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.